← Leaderboards
Rachel A Coulter
Nova Southeastern University
$894,309
Attributed
$894,309
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $192.3K · FY2005–18$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$894,309 · 2
By mechanism
U10$894,309 · 2
Top collaborators
No co-investigators on record.
Most similar at Nova Southeastern University
Same institution · by research overlap
- Dawn K Decarlo$1,191,593
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsEnsureDocumentationDesignEducational CurriculumData Coordinating CenterEligibility DeterminationAttention Deficit Hyperactivity DisorderAdvertisementsConvergence InsufficiencyAftercareChildChild CareAgedEnrollmentAttentionCognitiveCollegeCommunitiesBaseBehaviorConsentCaringEquipment
Grant awards (9)
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$1
U10 · FY2018 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$59,385
U10 · FY2017 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$157,169
U10 · FY2016 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$104,377
U10 · FY2015 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$192,295
U10 · FY2014 · EY · contact PI
Convergence Insufficiency Treatment Trial$58,983
U10 · FY2006 · EY · contact PI
Convergence Insufficiency Treatment Trial$158,772
U10 · FY2005 · EY
Convergence Insufficiency Treatment Trial$31,128
U10 · FY2005 · EY
Convergence Insufficiency Treatment Trial$132,199
U10 · FY2004 · EY